NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

More News From Enter Hollywood

Director Zhang Yimou wins Golden Horse Award for 'Shadow'

Dec 17, 2018

TAIPEI, Taiwan — Veteran director Zhang Yimou won best director at the Chinese-language version of the Oscars on Saturday night in Taiwan for his monochrome historical epic, "Shadow." The Golden Horse Awards honor films from Taiwan, Hong Kong, mainland China and other parts of the Chinese-speaking world, transcending political, cultural and geographic borders. This year's judging committee is led by Gong Li, the leading actress in many of Zhang's earlier films, who was invited by Ang Lee, director of Hollywood features such as "Brokeback Mountain" and "Hulk." "Shadow," which delves into the rich vein of Chinese martial arts and palace...

Rush's wife testifies actor wept denying allegations

Dec 17, 2018

SYDNEY — The wife of actor Geoffrey Rush cried as she told a Sydney court on Wednesday how he had wept and curled up in the fetal position following newspaper allegations he had behaved inappropriately toward a female co-star. Rush himself also admitted to the court he may have described the co-star, Eryn Jean Norvill, as "yummy", but denied this was accompanied by inappropriate hand gestures. Rush's wife Jane Menelaus, who's also an actor, wept as she appeared in the witness box at Sydney's Federal Court, where her Oscar-winning husband is suing the publisher of Sydney's Daily Telegraph newspaper, and...

Geoffrey Rush says he was 'distraught' over paper's articles

Dec 17, 2018

SYDNEY — Geoffrey Rush told the judge hearing his defamation case on Monday he felt distraught and as though his head was filled with lead on seeing a newspaper's publication of allegations he had behaved inappropriately toward a female co-star. The actor is suing the publishers of Sydney's Daily Telegraph newspaper and its journalist Jonathon Moran over the articles published last year. He denies all the allegations, but the journalists are pleading truth in their defense. Documents presented in court by the defense say the allegations concern Rush's behavior toward his co-star Eryn Jean Norvill during a Sydney Theatre Company...

Harry and Meghan travel in different style on Australia tour

Dec 17, 2018

SYDNEY — The Duke and Duchess of Sussex took separate boats Monday to Queensland's Fraser Island as their tour of Australia and the South Pacific continued with a reduced schedule for the pregnant duchess. Prince Harry took a barge for the 43-mile (70-kilometer) crossing from Australia's mainland to the island, while the former American actress Meghan rode in a far more comfortable cruiser. Meghan is some four months pregnant and has had her schedule reduced after a hectic start to the 16-day tour. The Duchess rested for the first part of the day while Harry undertook several engagements focusing on...

Meghan's schedule in Australia cut back after hectic start

Dec 17, 2018

SYDNEY — The pregnant Duchess of Sussex has had her schedule cut back during her first royal tour, after a hectic start to her visit to Australia and the South Pacific with husband Prince Harry. The tour is an extremely busy one, with the royal couple scheduled to attend more than 70 engagements during a 16-day trip across four countries. Meghan, who is due to give birth in the spring, skipped an event in Sydney on Sunday morning, leaving Harry to attend a cycling competition at the Invictus Games alone. She later joined the prince to watch sailing events, and...

Sign up now!